See other companies on Welcome to the Jungle
Summus
Virtual healthcare specialist platform
- 21-100 employees
- Healthcare
- B2C
- B2B
- Personal health
- Marketplace
- Midtown South, New York, NY
Jump to section
Company mission
Summus's mission is to restore human connection in healthcare.
28% employee growth in 12 months
Our take
Summus provides personalized health advice and connects patients with medical experts virtually. The company is part of the growing telehealth market, which is expected to be worth $197.5 billion globally by 2028.
Virtual care solutions have become heavily adopted in recent years, with the vast majority of physicians in the US now treating patients virtually. Summus hopes to take advantage of this burgeoning market, but also faces competition from the likes of Docly, Smart Doctor, and Maple.
As the healthcare provider continues to expand its operations, it has secured its position with acquisitions and partnerships, as well as raising over $40 million in funding. The telehealth marker it still developing, meaning Summus is well-placed to further strengthen its presence and build upon its already established success.
Freddie
Company Specialist at Welcome to the Jungle
Benefits
- Short & long term disability, voluntary supplemental life
- Access to Summus platform service with generous credits for family and friends
- 401k match
- Unlimited PTO
- Remote and in-office hybrid work model dependent upon role
- Medical & dental insurance
Company values
- Authenticity
- Accountability
- Excellence
Funding (last 2 of 5 rounds)
Aug 2023
$19.5m
LATE VC
Feb 2022
$22m
LATE VC
Total funding: $66.1m
Leadership
Julian Flannery
(Co-Founder & CEO)Served as Special Assistant to the Chief of Staff to the President of the United States. Was also Vice President for Morgan Stanley's Special Situations & Investment Banking division, and then Managing Director for Greyson Lehrman Group.
Jennifer Kherani, MD
(Co-Founder)Received an MD from Duke and became an Emergency Medicine physician at the New York-Presbyterian Hospital. Completed a post-doctoral research fellowship in neuroscience at Columbia University. Currently Head of Clinical Safety at Loxo Oncology at Lilly, alongside working at Summus.